{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:10:40Z","timestamp":1790831440391,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Agence nationale de la recherche","award":["ANR-18-RHUS-0012"],"award-info":[{"award-number":["ANR-18-RHUS-0012"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s00415-022-11356-9","type":"journal-article","created":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T20:02:32Z","timestamp":1662062552000},"page":"283-299","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Paraneoplastic neurological syndromes associated with renal or bladder cancer: case series and PRISMA-IPD systematic review"],"prefix":"10.1007","volume":"270","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9236-2428","authenticated-orcid":false,"given":"Macarena","family":"Villagr\u00e1n-Garc\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5958-3288","authenticated-orcid":false,"given":"Sergio","family":"Mu\u00f1iz-Castrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9555-4847","authenticated-orcid":false,"given":"Nicol\u00e1s Lundahl","family":"Ciano-Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3652-7061","authenticated-orcid":false,"given":"Alberto","family":"Vogrig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5551-0185","authenticated-orcid":false,"given":"Antonio","family":"Farina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1061-2321","authenticated-orcid":false,"given":"Marine","family":"Villard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri","family":"Psimaras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7220-2686","authenticated-orcid":false,"given":"Agusti","family":"Alentorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Fabien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2098-920X","authenticated-orcid":false,"given":"V\u00e9ronique","family":"Rogemond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4631-3056","authenticated-orcid":false,"given":"Bastien","family":"Joubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Honnorat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,1]]},"reference":[{"key":"11356_CR1","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001014","volume":"8","author":"F Graus","year":"2021","unstructured":"Graus F, Vogrig A, Mu\u00f1iz-Castrillo S, Antoine J-CG, Desestret V, Dubey D, Giometto B, Irani SR, Joubert B, Leypoldt F, McKeon A, Pr\u00fcss H, Psimaras D, Thomas L, Titulaer MJ, Vedeler CA, Verschuuren JJ, Dalmau J, Honnorat J (2021) Updated diagnostic criteria for paraneoplastic neurologic syndromes. Neurol Neuroimmunol Neuroinflamm 8:e1014. https:\/\/doi.org\/10.1212\/NXI.0000000000001014","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"11356_CR2","first-page":"143","volume-title":"Advances in clinical chemistry","author":"A Storstein","year":"2007","unstructured":"Storstein A, Vedeler CA (2007) Paraneoplastic neurological syndromes and onconeural antibodies: clinical and immunological aspects. Advances in clinical chemistry. Elsevier, Amsterdam, pp 143\u2013185"},{"key":"11356_CR3","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000883","volume":"7","author":"J H\u00e9bert","year":"2020","unstructured":"H\u00e9bert J, Riche B, Vogrig A, Mu\u00f1iz-Castrillo S, Joubert B, Picard G, Rogemond V, Psimaras D, Alentorn A, Berzero G, Desestret V, Rabilloud M, Honnorat J (2020) Epidemiology of paraneoplastic neurologic syndromes and autoimmune encephalitides in France. Neurol Neuroimmunol Neuroinflamm 7:e883. https:\/\/doi.org\/10.1212\/NXI.0000000000000883","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"11356_CR4","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s00415-016-8090-7","volume":"263","author":"A Storstein","year":"2016","unstructured":"Storstein A, Raspotnig M, Vitaliani R, Giometto B, Graus F, Grisold W, Honnorat J, Vedeler CA (2016) Prostate cancer, Hu antibodies and paraneoplastic neurological syndromes. J Neurol 263:1001\u20131007. https:\/\/doi.org\/10.1007\/s00415-016-8090-7","journal-title":"J Neurol"},{"key":"11356_CR5","unstructured":"Global Cancer Observatory. https:\/\/gco.iarc.fr\/. Accessed 11 Oct 2021"},{"key":"11356_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000224860","volume":"83","author":"E Sacco","year":"2009","unstructured":"Sacco E, Pinto F, Sasso F, Racioppi M, Gulino G, Volpe A, Bassi P (2009) Paraneoplastic syndromes in patients with urological malignancies. Urol Int 83:1\u201311. https:\/\/doi.org\/10.1159\/000224860","journal-title":"Urol Int"},{"key":"11356_CR7","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1002\/1531-8249(199906)45:6<805::AID-ANA18>3.0.CO;2-G","volume":"45","author":"JE Greenlee","year":"1999","unstructured":"Greenlee JE, Dalmau J, Lyons T, Clawson S, Smith RH, Pirch HR (1999) Association of anti-Yo (type I) antibody with paraneoplastic cerebellar degeneration in the setting of transitional cell carcinoma of the bladder: detection of Yo antigen in tumor tissue and fall in antibody titers following tumor removal. Ann Neurol 45:805\u2013809. https:\/\/doi.org\/10.1002\/1531-8249(199906)45:6%3c805::AID-ANA18%3e3.0.CO;2-G","journal-title":"Ann Neurol"},{"key":"11356_CR8","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1007\/s00415-002-0863-5","volume":"249","author":"IJ Sutton","year":"2002","unstructured":"Sutton IJ, Barnett MH, Watson JDG, Ell JJ, Dalmau J (2002) Paraneoplastic brainstem encephalitis and anti-Ri antibodies. J Neurol 249:1597\u20131598. https:\/\/doi.org\/10.1007\/s00415-002-0863-5","journal-title":"J Neurol"},{"key":"11356_CR9","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1002\/1097-0142(20010415)91:8<1423::AID-CNCR1148>3.0.CO;2-F","volume":"91","author":"CJ Prestigiacomo","year":"2001","unstructured":"Prestigiacomo CJ, Balmaceda C, Dalmau J (2001) Anti-Ri-associated paraneoplastic opsoclonus-ataxia syndrome in a man with transitional cell carcinoma\u2014a case report. Cancer 91:1423\u20131428. https:\/\/doi.org\/10.1002\/1097-0142(20010415)91:8%3c1423::AID-CNCR1148%3e3.0.CO;2-F","journal-title":"Cancer"},{"key":"11356_CR10","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3389\/fonc.2020.00350","volume":"10","author":"J Yang","year":"2020","unstructured":"Yang J, Li B, Li X, Lai Z (2020) Anti-N-methyl-D-aspartate receptor encephalitis associated with clear cell renal carcinoma: a case report. Front Oncol 10:350. https:\/\/doi.org\/10.3389\/fonc.2020.00350","journal-title":"Front Oncol"},{"key":"11356_CR11","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1002\/ana.410430522","volume":"43","author":"Y Shinohara","year":"1998","unstructured":"Shinohara Y, Ohnuki Y, Yoshii F, Takahashi W, Onoe K, Takagi S (1998) Detection of primary tumor in paraneoplastic cerebellar degeneration by FDG-PET. Ann Neurol 43:684. https:\/\/doi.org\/10.1002\/ana.410430522","journal-title":"Ann Neurol"},{"key":"11356_CR12","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1097\/SMJ.0b013e31816bea80","volume":"101","author":"H Ammar","year":"2008","unstructured":"Ammar H, Brown SH, Malani A, Sheth HK, Sollars EG, Zhou SX, Gupta C, Mughal S (2008) A case of paraneoplastic cerebellar ataxia secondary to renal cell carcinoma. South Med J 101:556\u2013557. https:\/\/doi.org\/10.1097\/SMJ.0b013e31816bea80","journal-title":"South Med J"},{"key":"11356_CR13","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1365-2990.2004.00609.x","volume":"31","author":"C Hagel","year":"2005","unstructured":"Hagel C, Stavrou D, Hansen HC (2005) Paraneoplastic frontal lobe disorder and ataxia in renal cell carcinoma. Neuropathol Appl Neurobiol 31:97\u201399. https:\/\/doi.org\/10.1111\/j.1365-2990.2004.00609.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"11356_CR14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40673-019-0102-9","volume":"6","author":"SM Souza","year":"2019","unstructured":"Souza SM, Santos BO, Sodr\u00e9 ICA, Oliveira ALP, Terrana D, Spitz M (2019) Paraneoplastic cerebellar degeneration as initial presentation of renal cell carcinoma. Cerebellum Ataxias 6:8. https:\/\/doi.org\/10.1186\/s40673-019-0102-9","journal-title":"Cerebellum Ataxias"},{"key":"11356_CR15","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s11060-008-9675-5","volume":"90","author":"V Johnson","year":"2008","unstructured":"Johnson V, Friedman N, Haller NA, Hagel C (2008) Immune mediated neurologic dysfunction as a paraneoplastic syndrome in renal cell carcinoma. J Neurooncol 90:279\u2013281. https:\/\/doi.org\/10.1007\/s11060-008-9675-5","journal-title":"J Neurooncol"},{"key":"11356_CR16","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1136\/jnnp.70.6.814","volume":"70","author":"MC Vigliani","year":"2001","unstructured":"Vigliani MC, Palmucci L, Polo P, Mutani R, Schiffer D, De Luca S, De Zan A (2001) Paraneoplastic opsoclonus-myoclonus associated with renal cell carcinoma and responsive to tumour ablation. J Neurol Neurosurg Psychiatry 70:814\u2013815. https:\/\/doi.org\/10.1136\/jnnp.70.6.814","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"11356_CR17","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1136\/jnnp.64.1.137","volume":"64","author":"A Koukoulis","year":"1998","unstructured":"Koukoulis A, Cimas I, G\u00f3mara S (1998) Paraneoplastic opsoclonus associated with papillary renal cell carcinoma. J Neurol Neurosurg Psychiatry 64:137\u2013138. https:\/\/doi.org\/10.1136\/jnnp.64.1.137","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"11356_CR18","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1001\/archneur.58.7.1133","volume":"58","author":"KA Kujawa","year":"2001","unstructured":"Kujawa KA, Niemi VR, Tomasi MA, Mayer NW, Cochran E, Goetz CG (2001) Ballistic-choreic movements as the presenting feature of renal cancer. Arch Neurol 58:1133\u20131135. https:\/\/doi.org\/10.1001\/archneur.58.7.1133","journal-title":"Arch Neurol"},{"key":"11356_CR19","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s11606-014-3172-7","volume":"30","author":"JW Harrison","year":"2015","unstructured":"Harrison JW, Cherukuri R, Buchan D (2015) Renal cell carcinoma presenting with paraneoplastic hallucinations and cognitive decline from limbic encephalitis. J Gen Intern Med 30:1037\u20131040. https:\/\/doi.org\/10.1007\/s11606-014-3172-7","journal-title":"J Gen Intern Med"},{"key":"11356_CR20","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/mdc3.12620","volume":"5","author":"K Colletta","year":"2018","unstructured":"Colletta K, Kartha N, Chawla J (2018) Paraneoplastic puzzle: an unusual case of hemichorea, renal cell carcinoma, and LGI1 antibody. Mov Disord Clin Pract 5:337\u2013338. https:\/\/doi.org\/10.1002\/mdc3.12620","journal-title":"Mov Disord Clin Pract"},{"key":"11356_CR21","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1212\/WNL.23.8.891","volume":"23","author":"DS Buchanan","year":"1973","unstructured":"Buchanan DS, Malamud N (1973) Motor neuron disease with renal cell carcinoma and postoperative neurologic remission: a clinicopathologic report. Neurology 23:891\u2013891. https:\/\/doi.org\/10.1212\/WNL.23.8.891","journal-title":"Neurology"},{"key":"11356_CR22","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.4103\/0028-3886.266293","volume":"67","author":"RR Mahale","year":"2019","unstructured":"Mahale RR, Mehta A, Buddaraju K, Javali M, Shankar AK, John AA, Srinivasa R (2019) Longitudinally extensive transverse myelitis with aquaporin-4 antibody positivity in renal cell carcinoma: rare occurrence. Neurol India 67:1087\u20131089. https:\/\/doi.org\/10.4103\/0028-3886.266293","journal-title":"Neurol India"},{"key":"11356_CR23","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1017\/s0317167100044942","volume":"10","author":"A Handforth","year":"1983","unstructured":"Handforth A, Nag S, Sharp D, Robertson DM (1983) Paraneoplastic subacute necrotic myelopathy. Can J Neurol Sci 10:204\u2013207. https:\/\/doi.org\/10.1017\/s0317167100044942","journal-title":"Can J Neurol Sci"},{"key":"11356_CR24","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1002\/mds.21374","volume":"22","author":"JC McHugh","year":"2007","unstructured":"McHugh JC, Murray B, Renganathan R, Connolly S, Lynch T (2007) GAD antibody positive paraneoplastic stiff person syndrome in a patient with renal cell carcinoma. Mov Disord 22:1343\u20131346. https:\/\/doi.org\/10.1002\/mds.21374","journal-title":"Mov Disord"},{"key":"11356_CR25","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1159\/000163053","volume":"18","author":"HM Turk","year":"2009","unstructured":"Turk HM, Ozet A, Kuzhan O, Komurcu F, Arpaci F, Ozturk B, Ataergin S (2009) Paraneoplastic motor neuron disease resembling amyotrophic lateral sclerosis in a patient with renal cell carcinoma. Med Princ Pract 18:73\u201375. https:\/\/doi.org\/10.1159\/000163053","journal-title":"Med Princ Pract"},{"key":"11356_CR26","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.eucr.2017.05.007","volume":"14","author":"N Ali","year":"2017","unstructured":"Ali N, Kutikov A, Geynisman DM (2017) Resolution of a debilitating paraneoplastic Parkinson-like neurological syndrome following tyrosine inhibitor therapy and consolidative nephrectomy in a patient with advanced clear cell renal cell carcinoma. Urol Case Rep 14:18\u201320. https:\/\/doi.org\/10.1016\/j.eucr.2017.05.007","journal-title":"Urol Case Rep"},{"key":"11356_CR27","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.clineuro.2018.08.020","volume":"173","author":"A de Alboniga-Chindurza","year":"2018","unstructured":"de Alboniga-Chindurza A, Riva E, Jimenez-Huete A, Graus F, Franch O (2018) Paraneoplastic stiff person syndrome with small cell carcinoma of the bladder and anti-Ri antibodies. Clin Neurol Neurosurg 173:194\u2013195. https:\/\/doi.org\/10.1016\/j.clineuro.2018.08.020","journal-title":"Clin Neurol Neurosurg"},{"key":"11356_CR28","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1002\/ana.10518","volume":"53","author":"SJ Pittock","year":"2003","unstructured":"Pittock SJ, Lucchinetti CF, Lennon VA (2003) Anti-neuronal nuclear autoantibody type 2: paraneoplastic accompaniments. Ann Neurol 53:580\u2013587. https:\/\/doi.org\/10.1002\/ana.10518","journal-title":"Ann Neurol"},{"key":"11356_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.598894","volume":"11","author":"M Zhu","year":"2020","unstructured":"Zhu M, Ma Y, Zekeridou A, Lennon VA (2020) Case report: innate immune system challenge unleashes paraneoplastic neurological autoimmunity. Front Neurol 11:598894. https:\/\/doi.org\/10.3389\/fneur.2020.598894","journal-title":"Front Neurol"},{"key":"11356_CR30","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.nrl.2016.05.010","volume":"33","author":"G Ortega Suero","year":"2018","unstructured":"Ortega Suero G, Sola-Valls N, Escudero D, Saiz A, Graus F (2018) Anti-Ma and anti-Ma2-associated paraneoplastic neurological syndromes. Neurologia 33:18\u201327. https:\/\/doi.org\/10.1016\/j.nrl.2016.05.010","journal-title":"Neurologia"},{"key":"11356_CR31","doi-asserted-by":"publisher","first-page":"E863","DOI":"10.1016\/j.clgc.2017.04.026","volume":"15","author":"H Anil","year":"2017","unstructured":"Anil H, Karamik K, Ates M, Yuksel M, Aktas Y, Erol I, Yildiz A, Savas M (2017) A rare clinical entity in bladder cancer: paraneoplastic cerebellar degeneration. Clin Genitourin Cancer 15:E863\u2013E865. https:\/\/doi.org\/10.1016\/j.clgc.2017.04.026","journal-title":"Clin Genitourin Cancer"},{"key":"11356_CR32","doi-asserted-by":"publisher","first-page":"724940","DOI":"10.1155\/2012\/724940","volume":"2012","author":"S Lukacs","year":"2012","unstructured":"Lukacs S, Szabo N, Woodhams S (2012) Rare association of anti-hu antibody positive paraneoplastic neurological syndrome and transitional cell bladder carcinoma. Case Rep Urol 2012:724940\u2013724940. https:\/\/doi.org\/10.1155\/2012\/724940","journal-title":"Case Rep Urol"},{"key":"11356_CR33","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1159\/000510742","volume":"13","author":"S Ketineni","year":"2020","unstructured":"Ketineni S, Kodali S, Gorantla S (2020) A rare case of sensory neuropathy associated with transitional cell carcinoma of the bladder. Case Rep Oncol 13:1397\u20131401. https:\/\/doi.org\/10.1159\/000510742","journal-title":"Case Rep Oncol"},{"key":"11356_CR34","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1186\/s12885-016-2349-3","volume":"16","author":"Y Zhu","year":"2016","unstructured":"Zhu Y, Chen S, Chen S, Song J, Chen F, Guo H, Shang Z, Wang Y, Zhou C, Shi B (2016) An uncommon manifestation of paraneoplastic cerebellar degeneration in a patient with high grade urothelial, carcinoma with squamous differentiation: a case report and literature review. BMC Cancer 16:324. https:\/\/doi.org\/10.1186\/s12885-016-2349-3","journal-title":"BMC Cancer"},{"key":"11356_CR35","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jns.2009.01.022","volume":"280","author":"F Forte","year":"2009","unstructured":"Forte F, Pretegiani E, Battisti C, Sicurelli F, Federico A (2009) Neuromyotonia as paraneoplastic manifestation of bladder carcinoma. J Neurol Sci 280:111\u2013112. https:\/\/doi.org\/10.1016\/j.jns.2009.01.022","journal-title":"J Neurol Sci"},{"key":"11356_CR36","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2014-208913","author":"G Thanarajasingam","year":"2015","unstructured":"Thanarajasingam G, Milone M, Kohli M (2015) Paraneoplastic encephalopathy: an unusual presenting feature of bladder cancer metastasis. BMJ Case Rep. https:\/\/doi.org\/10.1136\/bcr-2014-208913","journal-title":"BMJ Case Rep"},{"key":"11356_CR37","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1158\/1055-9965.EPI-06-0782","volume":"16","author":"AB Mariotto","year":"2007","unstructured":"Mariotto AB, Rowland JH, Ries LAG, Scoppa S, Feuer EJ (2007) Multiple cancer prevalence: a growing challenge in long-term survivorship. Cancer Epidemiol Biomark Prev 16:566\u2013571. https:\/\/doi.org\/10.1158\/1055-9965.EPI-06-0782","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"11356_CR38","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1212\/wnl.50.3.652","volume":"50","author":"CF Lucchinetti","year":"1998","unstructured":"Lucchinetti CF, Kimmel DW, Lennon VA (1998) Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies. Neurology 50:652\u2013657. https:\/\/doi.org\/10.1212\/wnl.50.3.652","journal-title":"Neurology"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11356-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-022-11356-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11356-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T17:18:24Z","timestamp":1672852704000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-022-11356-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["11356"],"URL":"https:\/\/doi.org\/10.1007\/s00415-022-11356-9","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,1]]},"assertion":[{"value":"20 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Macarena Villagr\u00e1n-Garc\u00eda received a fellowship grant from the Spanish Society of Neurology.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}},{"value":"The authors declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All patients recruited in the French Reference Centre on Paraneoplastic Neurologic Syndromes and Autoimmune Encephalitis (Lyon, France) provided written informed consent for the storage and use of their serum and cerebrospinal fluid (CSF) samples and clinical information for research purposes. The Institutional Review Board of the <i>Universit\u00e9 Claude Bernard Lyon 1<\/i> and <i>Hospices Civils de Lyon<\/i> approved the study (GenePNS, 19-62, NCT-03963700). The study was performed in accordance with the ethical standards framed by the Declaration of Helsinki and its later amendments.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}